Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses

被引:139
作者
Kwon, OB
Longart, M
Vullhorst, D
Hoffman, DA
Buonanno, A
机构
[1] NICHHD, NIH, Sect Mol Neurobiol, Bethesda, MD 20892 USA
[2] NICHHD, NIH, Unit Neurophysiol & Biophys, Bethesda, MD 20892 USA
关键词
neuregulin; depotentiation; ErbB receptor; LTP; LTD; schizophrenia; superecliptic GFP;
D O I
10.1523/JNEUROSCI.2100-05.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuregulin-1 (NRG-1) has been identified genetically as a schizophrenia susceptibility gene, but its function in the adult brain is unknown. Here, we show that NRG-1 beta does not affect basal synaptic transmission but reverses long-term potentiation (LTP) at hippocampal Schaffer collateral -> CA1 synapses in an activity- and time-dependent manner. Depotentiation by NRG-1 beta is blocked by two structurally distinct and selective ErbB receptor tyrosine kinase inhibitors. Moreover, ErbB receptor inhibition increases LTP at potentiated synapses and blocks LTP reversal by theta-pulse stimuli. NRG-1 beta selectively reduces AMPA, not NMDA, receptor EPSCs and has no effect on paired-pulse facilitation ratios. Live imaging of hippocampal neurons transfected with receptors fused to superecliptic green fluorescent protein, as well as quantitative analysis of native receptors, show that NRG-1 beta stimulates the internalization of surface glutamate receptor 1-containing AMPA receptors. This novel regulation of LTP by NRG-1 has important implications for the modulation of synaptic homeostasis and schizophrenia.
引用
收藏
页码:9378 / 9383
页数:6
相关论文
共 40 条
[1]   Metaplasticity: The plasticity of synaptic plasticity [J].
Abraham, WC ;
Bear, MF .
TRENDS IN NEUROSCIENCES, 1996, 19 (04) :126-130
[2]  
Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO
[3]  
2-2
[4]   Cognitive neuroscience [J].
Albright, TD ;
Kandel, ER ;
Posner, MI .
CURRENT OPINION IN NEUROBIOLOGY, 2000, 10 (05) :612-624
[5]   It's green outside: tracking cell surface proteins with pH-sensitive GFP [J].
Ashby, MC ;
Ibaraki, K ;
Henley, JM .
TRENDS IN NEUROSCIENCES, 2004, 27 (05) :257-261
[6]   A SYNAPTIC MODEL OF MEMORY - LONG-TERM POTENTIATION IN THE HIPPOCAMPUS [J].
BLISS, TVP ;
COLLINGRIDGE, GL .
NATURE, 1993, 361 (6407) :31-39
[7]   OPTIMIZED SURVIVAL OF HIPPOCAMPAL-NEURONS IN B27-SUPPLEMENTED NEUROBASAL(TM), A NEW SERUM-FREE MEDIUM COMBINATION [J].
BREWER, GJ ;
TORRICELLI, JR ;
EVEGE, EK ;
PRICE, PJ .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 35 (05) :567-576
[8]   Neuregulin and ErbB receptor signaling pathways in the nervous system [J].
Buonanno, A ;
Fischbach, GD .
CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (03) :287-296
[9]   Neuregulin-1 and ErbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease [J].
Chaudhury, AR ;
Gerecke, KM ;
Wyss, JM ;
Morgan, DG ;
Gordon, MN ;
Carroll, SL .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (01) :42-54
[10]   Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia [J].
Corfas, G ;
Roy, K ;
Buxbaum, J .
NATURE NEUROSCIENCE, 2004, 7 (06) :575-580